
Rainbow Children’s Medicare Q2 Results 2025 Highlights: Net Profit Falls 4.59% & Revenue Up 6.55% YoY
Click and Sign Up to Get Live Updates on Q2 Results
Updated: 20 Nov 2025 • 7:18 pm
Posted by:

Rainbow Childrens Medicare Q2 Results FY26: During Q2 FY26, Rainbow Children’s Medicare's profit decreased 4.59% YoY, while revenue increased by 6.55% YoY. The company posted robust numbers, with Q2 PAT at ₹75.25 crores and revenue at ₹444.80 crores. Rainbow Children’s Medicare announced its Q2 results on 13th November 2025.
Rainbow Childrens Medicare Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹444.80 | ₹417.46 |
| Profit Before Tax (PBT) | ₹157.06 | ₹158.35 |
| Profit After Tax (PAT) | ₹75.25 | ₹78.87 |
(Figures in crores)
Rainbow Childrens Medicare Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹408.50 | ₹403.93 |
| Profit Before Tax (PBT) | ₹148.89 | ₹154.21 |
| Profit After Tax (PAT) | ₹73.17 | ₹77.34 |
(Figures in crores)
Rainbow Childrens Medicare Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Rainbow Children’s Medicare clocked Q2 FY26 consolidated revenue of ₹444.80 crores vs ₹417.46 crores.
- On the profit front, Rainbow Children’s Medicare earned a consolidated PAT of ₹75.25 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹78.87 crore.
- According to the consolidated figures, Rainbow Children’s Medicare's quarterly PAT decreased by 4.59% YoY, while revenue increased by 6.55%.
- Rainbow Children’s Medicare clocked Q2 FY26 standalone revenue of ₹408.50 crores vs ₹403.93 crores.
- On the profit front, Rainbow Children’s Medicare earned a standalone PAT of ₹73.17 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹77.34 crore.
- According to the standalone figures, Rainbow Children’s Medicare's quarterly PAT decreased by 5.40% YoY, while revenue increased by 1.13%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Rainbow Childrens Medicare Share Price Performance
On the opening bell on 20th November 2025, Rainbow Children’s Medicare shares opened at ₹1,339.00 per share. However, the initial gains have since eroded, and Rainbow Children’s Medicare shares are currently trading at ₹1,337.90 per share, lower than the opening price.
Considering the long-term performance, Rainbow Children’s Medicare shares have yielded returns of approximately -1.66% over the past 6 months and -14.28% over the past 1 year. Over the maximum timeframe, Rainbow Children’s Medicare shares delivered a return of 162.98% to investors.
What Analysts Expect Post Q2 Results?
Following Rainbow Children’s Medicare's robust Q2 results, analysts expect its share price to rise. According to analysts, Rainbow Children’s Medicare's share price is expected to reach ₹1,420.30 per share in the coming year; however, in a downturn, it could fall to ₹1,309.40 per share. However, one must ignore stock market volatility and invest in Rainbow Children’s Medicare's shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Recent Articles

Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
23 October 2026

Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
23 October 2026

Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
23 October 2026

Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
23 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
Himadri Speciality Share Price Posts Its Biggest Weekly Fall Since 2008: What Q2 FY27 Margins, Valuation and Guidance Say
Popular this week
Smallcap Stocks Falling Today: Why Mid and Small-Caps Are Bleeding as Swiggy, Meesho, Vedanta Aluminium and MCX Lose Big

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





